miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
Miliotis, Christos, and Frank J Slack. 2021. “MiR-105-5p Regulates PD-L1 Expression and Tumor Immunogenicity in Gastric Cancer.”. Cancer Letters 518: 115-26.
Search
Search results
5012 results found
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
Li, Wen Jess, Yunfei Wang, Ruifang Liu, Andrea L Kasinski, Haifa Shen, Frank J Slack, and Dean G Tang. 2021. “MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.”. Frontiers in Cell and Developmental Biology 9: 640587.
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
Malik, Shipra, Jihoon Lim, Frank J Slack, Demetrios T Braddock, and Raman Bahal. 2020. “Next Generation MiRNA Inhibition Using Short Anti-Seed PNAs Encapsulated in PLGA Nanoparticles.”. Journal of Controlled Release : Official Journal of the Controlled Release Society 327: 406-19.
Challenges identifying efficacious miRNA therapeutics for cancer.
Segal, Meirav, and Frank J Slack. 2020. “Challenges Identifying Efficacious MiRNA Therapeutics for Cancer.”. Expert Opinion on Drug Discovery 15 (9): 987-92.
ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya, Julia, Allison R Baker, Frank J Slack, and Pilar Santisteban. 2020. “ADAR1-Mediated RNA Editing Is a Novel Oncogenic Process in Thyroid Cancer and Regulates MiR-200 Activity.”. Oncogene 39 (18): 3738-53.
C. elegans sym-1 is a downstream target of the hunchback-like-1 developmental timing transcription factor.
Niwa, Ryusuke, Kazumasa Hada, Kouichi Moliyama, Ryosuke L Ohniwa, Yi-Meng Tan, Katherine Olsson-Carter, Woo Chi, Valerie Reinke, and Frank J Slack. 2009. “C. Elegans Sym-1 Is a Downstream Target of the Hunchback-Like-1 Developmental Timing Transcription Factor.”. Cell Cycle (Georgetown, Tex.) 8 (24): 4147-54.
An elegant miRror: microRNAs in stem cells, developmental timing and cancer.
Nimmo, Rachael A, and Frank J Slack. 2009. “An Elegant MiRror: MicroRNAs in Stem Cells, Developmental Timing and Cancer.”. Chromosoma 118 (4): 405-18.
MicroRNA in cancer prognosis.
Slack, Frank J, and Joanne B Weidhaas. 2008. “MicroRNA in Cancer Prognosis.”. The New England Journal of Medicine 359 (25): 2720-2.
microRNAs and cancer: an overview.
Medina, Pedro P, and Frank J Slack. 2008. “MicroRNAs and Cancer: An Overview.”. Cell Cycle (Georgetown, Tex.) 7 (16): 2485-92.
The let-7 microRNA reduces tumor growth in mouse models of lung cancer.
Esquela-Kerscher, Aurora, Phong Trang, Jason F Wiggins, Lubna Patrawala, Angie Cheng, Lance Ford, Joanne B Weidhaas, David Brown, Andreas G Bader, and Frank J Slack. 2008. “The Let-7 MicroRNA Reduces Tumor Growth in Mouse Models of Lung Cancer.”. Cell Cycle (Georgetown, Tex.) 7 (6): 759-64.